Measures at state level - I
Supply-side (price)
- Rebates and Drug Discounts
- Adopting state rules for pharmacy reimbursement
- Negotiating rebates beyond minimum statutory level
- Maximum Allowable Cost Programmes (or State Upper Payment Limits)
- State Pricing and other Purchasing Initiatives
- Maine price control act
- Parallel reimportation bill (federal)
- Disregard AMP and AWP and substitute for ASP
- Debating legitimacy of OBRA and relation with other Acts
- Waxman-Hatch and timely generic penetration
- Waxman-Hatch and market exclusivity for first generic